These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 25765936

  • 1. Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models.
    Abdurrachim D, Luiken JJ, Nicolay K, Glatz JF, Prompers JJ, Nabben M.
    Cardiovasc Res; 2015 May 01; 106(2):194-205. PubMed ID: 25765936
    [Abstract] [Full Text] [Related]

  • 2. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ.
    Cardiovasc Res; 2009 Feb 15; 81(3):420-8. PubMed ID: 18854380
    [Abstract] [Full Text] [Related]

  • 3. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
    Lopaschuk GD.
    Semin Cardiothorac Vasc Anesth; 2006 Sep 15; 10(3):228-30. PubMed ID: 16959756
    [Abstract] [Full Text] [Related]

  • 4. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A, Milner K, Gupta A, Lopaschuk GD.
    Curr Pharm Des; 2015 Sep 15; 21(25):3654-64. PubMed ID: 26166604
    [Abstract] [Full Text] [Related]

  • 5. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P, Sampath H, Dobrzyn A, Miyazaki M, Ntambi JM.
    Am J Physiol Endocrinol Metab; 2008 Feb 15; 294(2):E357-64. PubMed ID: 18042664
    [Abstract] [Full Text] [Related]

  • 6. Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.
    Bedi KC, Snyder NW, Brandimarto J, Aziz M, Mesaros C, Worth AJ, Wang LL, Javaheri A, Blair IA, Margulies KB, Rame JE.
    Circulation; 2016 Feb 23; 133(8):706-16. PubMed ID: 26819374
    [Abstract] [Full Text] [Related]

  • 7. [Metabolic therapy for heart failure].
    Loiacono F, Alberti L, Lauretta L, Puccetti P, Silipigni C, Margonato A, Fragasso G.
    Recenti Prog Med; 2014 Feb 23; 105(7-8):288-94. PubMed ID: 25072544
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
    Fukushima A, Lopaschuk GD.
    Biochim Biophys Acta; 2016 Dec 23; 1862(12):2211-2220. PubMed ID: 27479696
    [Abstract] [Full Text] [Related]

  • 12. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
    van Bilsen M, Smeets PJ, Gilde AJ, van der Vusse GJ.
    Cardiovasc Res; 2004 Feb 01; 61(2):218-26. PubMed ID: 14736538
    [Abstract] [Full Text] [Related]

  • 13. Myocardial substrate metabolism in the normal and failing heart.
    Stanley WC, Recchia FA, Lopaschuk GD.
    Physiol Rev; 2005 Jul 01; 85(3):1093-129. PubMed ID: 15987803
    [Abstract] [Full Text] [Related]

  • 14. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
    Fukushima A, Lopaschuk GD.
    Biochim Biophys Acta; 2016 Oct 01; 1861(10):1525-34. PubMed ID: 26996746
    [Abstract] [Full Text] [Related]

  • 15. Energy metabolism in cardiac remodeling and heart failure.
    Azevedo PS, Minicucci MF, Santos PP, Paiva SA, Zornoff LA.
    Cardiol Rev; 2013 Oct 01; 21(3):135-40. PubMed ID: 22990373
    [Abstract] [Full Text] [Related]

  • 16. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T, Pytel G, Schrepper A, Amorim P, Färber G, Shingu Y, Mohr FW, Schwarzer M.
    Cardiovasc Res; 2010 Jun 01; 86(3):461-70. PubMed ID: 20035032
    [Abstract] [Full Text] [Related]

  • 17. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
    Kerr M, Dodd MS, Heather LC.
    Clin Sci (Lond); 2017 Aug 15; 131(16):2079-2094. PubMed ID: 28739841
    [Abstract] [Full Text] [Related]

  • 18. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J, Zhang L, Oudit GY, Lopaschuk GD.
    J Mol Cell Cardiol; 2013 Oct 15; 63():98-106. PubMed ID: 23886814
    [Abstract] [Full Text] [Related]

  • 19. Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases.
    Actis Dato V, Lange S, Cho Y.
    Int J Mol Sci; 2024 Jan 19; 25(2):. PubMed ID: 38279217
    [Abstract] [Full Text] [Related]

  • 20. Targeting myocardial substrate metabolism in heart failure: potential for new therapies.
    Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M.
    Eur J Heart Fail; 2012 Feb 19; 14(2):120-9. PubMed ID: 22253453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.